Pak J Biol Sci. 2021 Jan;24(9):953-970. doi: 10.3923/pjbs.2021.953.970.
<b>Background and Objective:</b> Nanobacteria (NB) appear to contribute to many calcifying diseases including kidney stones which represent a common problem with inadequate prevention exist. NB framing itself with a mineral coat that assists as a primary defence shield against the immune system, antibiotics. This study aims to collect and detect nanobes from different kidney stones from patients with active urolithiasis then investigated the anti-nano-bacterial activity of some antibiotics alone or in combination with extracts of irradiated herbs of certain medicinal plants which will represent a new approach to therapy for patients with kidney stones. <b>Materials and Methods:</b> Total of 32 nanobes were isolated from 54 kidney stones. Fourier Transforms Infrared Spectroscopy (FTIR) revealed that calcium and phosphate are the main components of stones. Scanning Electron Microscopy (SEM) with Energy-dispersive X-ray spectroscopy (EDX) and Transmission Electron Microscope (TEM), showed that nanobes were Gram-ve cocci with size ranged from (375:600 nm). The biofilm production ability of nanobes was estimated qualitatively and quantitatively. <b>Results:</b> The results revealed that all were strong biofilm producers. Further, the antibiotic susceptibility test indicates their resistance towards most of the tested antibiotics. Molecular identification of the strong biofilm producer isolates by ribosomal ribonucleic acid (rRNA) revealed that it is indicated by 85.37% to <i>Bartonella apis</i> strain PEB0122. <b>Conclusion:</b> The findings of the current study evidenced that combination treatment between Doxycycline (DO) and water extract of khella exhibited a significant reduction in biofilm formation ability of the strongest producers nanobes. Therefore, this treatment can play a role in enhancing public health, especially with patients who suffer from recurrent kidney stone formation.
纳米细菌(NB)似乎与许多钙化疾病有关,包括肾结石,这是一个普遍存在的问题,预防措施不足。NB 用矿物质涂层包裹自身,作为对抗免疫系统和抗生素的第一道防御屏障。本研究旨在从活动期尿石症患者的不同肾结石中收集和检测纳米细菌,然后研究单独使用或联合使用某些药用植物辐照提取物的抗生素的抗纳米细菌活性,这将为肾结石患者的治疗提供新方法。
从 54 个肾结石中总共分离出 32 个纳米细菌。傅里叶变换红外光谱(FTIR)显示钙和磷酸盐是结石的主要成分。扫描电子显微镜(SEM)结合能量色散 X 射线光谱(EDX)和透射电子显微镜(TEM)显示,纳米细菌是革兰氏阴性球菌,大小范围为(375:600nm)。通过定性和定量方法评估纳米细菌生物膜产生能力。
结果表明,所有纳米细菌都是强生物膜生产者。此外,抗生素药敏试验表明,它们对大多数测试的抗生素都有耐药性。通过核糖体核糖核酸(rRNA)对强生物膜生产者分离株进行分子鉴定,结果表明,其与 85.37%的蜂房巴通体(Bartonella apis)PEB0122 菌株一致。
本研究的结果表明,强力生物膜生产者纳米细菌的联合治疗,多西环素(DO)与水芹水提取物之间具有显著降低生物膜形成能力的作用。因此,这种治疗方法可以在增强公共卫生方面发挥作用,特别是对患有复发性肾结石形成的患者。